Seeking Alpha

Celsion (CLSN) says ThermoDox missed its primary endpoint in a Phase III trial for liver cancer...

Celsion (CLSN) says ThermoDox missed its primary endpoint in a Phase III trial for liver cancer patients. (PR)
Comments (4)
  • harnettdj
    , contributor
    Comments (118) | Send Message
     
    OUCH
    31 Jan 2013, 09:54 AM Reply Like
  • TiantongQ
    , contributor
    Comments (246) | Send Message
     
    Thanks biotech sage for saving me. I did however lose on AAPL
    31 Jan 2013, 10:48 AM Reply Like
  • amermarie
    , contributor
    Comment (1) | Send Message
     
    it dropped 85%
    31 Jan 2013, 12:24 PM Reply Like
  • sanchezliz48@yahoo.com
    , contributor
    Comments (8) | Send Message
     
    We led on a rough ride down a rocky path to nowhere !!!!!
    31 Jan 2013, 12:31 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|